| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 05/28/2008 | EP1924270A2 Iron (iii) complex compounds for treating iron deficiency in patients with chronic inflammatory intestinal diseases |
| 05/28/2008 | EP1496898B1 Tyrosine kinase inhibitors |
| 05/28/2008 | EP1494992B1 Carbocyclic and oxacarbocyclic fumaric acid oligomers |
| 05/28/2008 | EP1424326B1 Fused-polycyclic compounds |
| 05/28/2008 | EP1420020B1 4-oxoimidazolidine-2-spiropiperidine derivative |
| 05/28/2008 | EP1326630B1 Use of glp-2 peptides |
| 05/28/2008 | CN101189334A 抗cd14抗体融合蛋白质 Anti-cd14 antibody fusion proteins |
| 05/28/2008 | CN101189236A Pyrazolo[1,5-a]pyridine derivatives or pharmaceutically acceptable salts thereof |
| 05/28/2008 | CN101189023A 监测和调制hgf/hgfr活性 Monitoring and modulation hgf / hgfr activity |
| 05/28/2008 | CN101186923A CDNA sequence of coding perinereis albuhitensis grube protease and amino acid sequence thereof |
| 05/28/2008 | CN101186646A Application of king cobra toxin protease inhibitor and its derivatives |
| 05/28/2008 | CN101185759A Anti-angiogene compositions and methods of use |
| 05/28/2008 | CN101185737A Orally-administered traditional Chinese medicine for treating stomach-heat type hematemesis |
| 05/28/2008 | CN101185709A Chinese herbal medicine for treating apoplexy sequelae (hemiparalysis) |
| 05/28/2008 | CN101185658A Intermediate compound of a liquid state traditional Chinese medicinal preparation and preparation method and application thereof |
| 05/28/2008 | CN101185657A Production process and device for donkey-hide gelatin plasma substitutes |
| 05/28/2008 | CN101185649A Levoleucovorin freeze-dried injection agent and preparation method and pharmaceutical use thereof |
| 05/28/2008 | CN101185639A Alprostadil nano lipid carrier and preparation method thereof |
| 05/28/2008 | CN101185509A Medicinal food for spleen-invigorating and blood-nourishing |
| 05/28/2008 | CN100390203C Hyperbranched amylopectin for use in methods for surgical or therapeutic treatment of mammals or in diagnostic methods expecially for use as a plasma volume expander |
| 05/28/2008 | CN100390201C Fusion protein with reinforced erythrocytin activity in vivo |
| 05/28/2008 | CN100390179C Arylamine substututed bicyclic heteroaromatic compounds as p38 kinase inhibitors |
| 05/28/2008 | CN100390178C Polycycloalkylpurines as adenosine receptor antagonists |
| 05/28/2008 | CN100390174C Methylamino-pterin derivative with inhibiting nitric oxide synthetase function |
| 05/28/2008 | CN100390160C Process for the preparation of arylethanoldiamines useful as agonists of the beta-3-adrenoceptor |
| 05/28/2008 | CN100390136C Abiotic heparin antagonists |
| 05/28/2008 | CN100390135C Novel derivatives of dicarboxylic acid having pharmaceutical properties |
| 05/28/2008 | CN100389822C Pyridoxal phosphate internally cross-linked hematoglobin nanocapsule and its preparing method |
| 05/28/2008 | CN100389756C Powdery wound paste with instant soluble seal and production thereof |
| 05/27/2008 | US7378529 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 05/27/2008 | US7378488 for promoting the release of growth hormone and of enhancing wound healing in a human or animal subject; for treating short stature, cachexia, wasting, type 2 diabetes, and poor circulation |
| 05/27/2008 | US7378430 inhibitors of cGMP PDE, especially Type 5; erectile dysfunction and sexual disorders; 6-Bromo-N-[(3-chloro-methoxyphenyl)methyl]-2-(2-pyridinyl)-4-quinolinamine |
| 05/27/2008 | US7378404 For therapy of estrogen-deficiency-induced diseases and conditions |
| 05/27/2008 | US7378393 Recombinant anticoagulant proteins |
| 05/27/2008 | US7378077 Hydrating a leukemia patient; parenterally administering a dose samarium ethylenediaminetetramethylenephosphonic acid (EDTMP); and melphalan, busulfan, and/or cyclophosphamiide; anticarcinogenic, antitumor, and antantiproliferative agents; autoimmune, infectious , metabolic or genetic disorders |
| 05/27/2008 | CA2423357C Fused heterocyclic derivatives as phosphodiesterase inhibitors |
| 05/27/2008 | CA2272063C Antithrombotic organic nitrates |
| 05/27/2008 | CA2258494C Polypeptides capable of forming antigen binding structures with specificity for the rhesus d antigens, the dna encoding them and the process for their preparation and use |
| 05/22/2008 | WO2008059917A1 Thrombin mutant |
| 05/22/2008 | WO2008059869A1 Method of degrading polysaccharide |
| 05/22/2008 | WO2008059029A2 New polymorphs of ethyl 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazole-5-carbonyl)-pyridin-2-yl-amino]-propionate |
| 05/22/2008 | US20080119534 Benzimidazole Derivatives as Therapeutic Agents |
| 05/22/2008 | US20080119523 3-[(2-{[4-(hexyloxycarbonylaminoiminomethyl) phenylamino]methyl}-1-methyl-1h-benzimidazol-5- carbonyl)pyridin-2-ylamino]propionic acid ethylester methansulfonate and its use as a medicament |
| 05/22/2008 | US20080119512 Carboxamide Derivatives as Therapeutic Agents |
| 05/22/2008 | US20080119438 medium molecular weight heparin ranging from 6,000 Daltons to 12,000 Daltons composition, has sufficient length to bridge antithrombin to thrombin, comprising a mixture of sulfated oligosaccharides; treating cardiovascular diseases, preventing the formation of a thrombus, arterial/deep vein thrombosis |
| 05/22/2008 | CA2669641A1 Thrombin mutant |
| 05/22/2008 | CA2669396A1 New polymorphs of ethyl 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazole-5-carbonyl)-pyridin-2-yl-amino]-propionate |
| 05/21/2008 | EP1923391A1 Substituted heterocyclic compounds, method for preparing same and pharmaceutical compositions containing them. |
| 05/21/2008 | EP1923388A1 Brain/neuronal cell-protecting agent, and therapeutic agent for sleep disorder |
| 05/21/2008 | EP1922073A1 New capped pyrazinoylguanidine sodium channel blockers |
| 05/21/2008 | EP1531791A4 Prevention and reduction of blood loss |
| 05/21/2008 | EP1385508B1 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 05/21/2008 | EP1362027B1 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical |
| 05/21/2008 | EP1326838B1 Novel crystalline forms of a factor xa inhibitor |
| 05/21/2008 | EP1313453B1 Particulate vectors for improving oral absorption of active principles |
| 05/21/2008 | EP1284734B1 Isoquinoline derivatives as protein kinase inhibitors |
| 05/21/2008 | EP1054687B1 Expression vectors and cell lines expressing vascular endothelial growth factor d, and method of treating melanomas |
| 05/21/2008 | DE102006054005A1 Neue Polymorphe von New polymorphs of 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester |
| 05/21/2008 | CN101184474A A closed container comprising an activated factor vii polypeptide, processes for the preparation of the same, and a kit and a method for use of the kit |
| 05/21/2008 | CN101184390A Reduced foam dispersions and formulations therefor |
| 05/21/2008 | CN101182355A Antibacterial peptide fusion protein gene, recombinant carrier thereof, transformant and expression product thereof |
| 05/21/2008 | CN101182289A 4'-hydroxy-4,6'-dimethoxy dihydrocharcone and method for synthesizing the same |
| 05/21/2008 | CN101181618A Medicine for curing thrombus as well as preparation method thereof |
| 05/21/2008 | CN101181606A Medicament with the efficacy of expelling-wind arefaction, anti-inflammation detumescence, hemostasis and pain-relieving |
| 05/21/2008 | CN101181590A Quality standard of wei-xue-kang mastication tablet as well as verification method thereof |
| 05/21/2008 | CN101181584A Chinese medicine prescription orally taken for curing leukocytopenia |
| 05/21/2008 | CN101181526A Medical hongshang hemostatic medicament and preparation method thereof |
| 05/21/2008 | CN101181476A External application medicine for curing podosoma phlebothrombosis and phlebitis as well as preparation method |
| 05/21/2008 | CN101181440A Chinese medicine composition for curing hemopathy as well as preparation method and usage thereof |
| 05/21/2008 | CN101181414A Chinese medicine prescription for hemostasis as well as manufacturing method |
| 05/21/2008 | CN101181412A Chinese medicine prescription orally taken for curing leukocytopenia |
| 05/21/2008 | CN101181347A Pastille soft capsule and preparation method thereof |
| 05/21/2008 | CN101181346A Duyiwei soft capsule and preparation method thereof |
| 05/21/2008 | CN101181340A Astragalus essence effervescent tablets and preparation method thereof |
| 05/21/2008 | CN101181329A Total chromocor extract of blumea riparia as well as pharmaceutical composition and preparing method thereof |
| 05/21/2008 | CN101181326A Notoginsen triterpenes freeze-dried powder pin preparations for injections and preparation method thereof |
| 05/21/2008 | CN101181292A Tea polyoses oral liquid |
| 05/21/2008 | CN101181291A Tea polyoses injection |
| 05/21/2008 | CN101181288A Solid-state molecule disperse preparations of pennogenin series compounds |
| 05/20/2008 | US7375205 Elongase genes and uses thereof |
| 05/20/2008 | US7375136 Such as 1-(4-methanesulphonamidepheoxy)3-(N-methyl-3,4-dichlorophenylethylamino)-2-propanol; synthesis; effective against brain and/or spinal cord tissue acidification disorders |
| 05/20/2008 | US7375131 NF-κB inhibitors |
| 05/20/2008 | US7375128 Inhibitors of α1 β2 integrin mediated cell adhesion |
| 05/20/2008 | US7375121 Chemical compounds |
| 05/20/2008 | US7375119 Novel inhibitor of FXa that can be administered orally; less toxic; enzyme selectivity; high bioavailability; treatment of diseases caused by thrombi or emboli; N-(5-Chloropyridin-2-yl)-5-methoxy-2-({[trans-4-(3-oxomorpholin-4-yl)cyclohexyl]carbonyl}amino)benzamide |
| 05/20/2008 | US7375113 Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs |
| 05/20/2008 | US7375103 (-)-7-[2-(cyclopropylmethoxy)-6-hydroxyphenyl]-5-[(3S)-3-piperidinyl]-1,4-dihydro-2H-pyrido[2,3-d][1,3]oxazin-2-one or salt as I kappa-B kinase inhibitor; antiinflammatory agent; autoimmune diseases, ischemia, cancer |
| 05/20/2008 | US7375101 N-(7-chloro-2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl)-N'-(5isoquinolinyl)-thiourea; bradykinin receptor B2 antagonists;analgesic; septic shock, pancreatitis, edema, rhinitis, asthma, colitis, arthritis, hepatorenal syndrome, cancer, bacterial and viral infections, ulcerative colitis |
| 05/20/2008 | US7374892 Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases |
| 05/20/2008 | CA2415681C Pyrrolidine derivatives |
| 05/20/2008 | CA2317465C Synthetic polysaccharides, their method of production and pharmaceutical compositions containing same |
| 05/20/2008 | CA2222755C Separation of hemoglobin on hydroxyapatite using hplc |
| 05/20/2008 | CA2214685C Benzamidine derivatives their preparation and their use as anti-coagulants |
| 05/20/2008 | CA2177695C Method of transmitting a biologically active material to a cell |
| 05/15/2008 | WO2008057972A1 Methods of synthesizing pharmaceutical salts of a factor xa inhibitor |
| 05/15/2008 | WO2008036843A3 Nitrogen containing substituted heterocycles as platelet adp receptor inhibitors |
| 05/15/2008 | WO2007121312A3 Trivalent chromium compounds, compositions and methods of use |
| 05/15/2008 | US20080114285 Energy-activated targeted cancer therapy |
| 05/15/2008 | US20080114081 Pleckstrin homology domains (PH); gene therapy; mimetics |
| 05/15/2008 | US20080114051 Pyrrolidine derivatives as prostaglandin modulators |